pharmavoice
The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development. These, and other factors, contribute to unsustainable costs and longer timelines before much-needed therapies reach the market.
Watch Now
IIdiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias and life-threatening multi-organ dysfunction.
Watch Now
Business-review-webinars
Most informed consent forms are not patient focused and do not support the needs of the study participant! Use of electronic consent can help improve the current paper document approach, but there is more to it than just replacing paper with a multi-media eConsent. What does it take to make eConsent patient centric?
Watch Now
Psychedelic-class drugs like psilocybin, ketamine and MDMA are powerful probes of conscious states with tremendous promise for an array of psychiatric conditions. Each compound has a unique set of effects, some desirable and others less-so, often dependent on the setting in which they are given.
Watch Now